요즈마 그룹 코리아요즈마 그룹 코리아
  • Korean
  • About
    • Chairman
    • Overview
    • People
      • Team
      • Advisors & Partners
      • Advisors & Partners
  • Business
  • YIC
  • Portfolio
  • Newsroom
  • Contact
Press enter to begin your search
Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT

Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT

관리정경단 2023-08-17 August 22nd, 2023

Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT

https://www.globenewswire.com/en/news-release/2023/08/17/2727669/0/en/Alpha-Tau-Announces-Robust-Long-Term-Safety-and-Efficacy-Data-from-Multiple-Clinical-Trials-of-Alpha-DaRT.html

Tags:

AlphaTau알파타우
Press Release No Comments
Share Tweet Share Pin

Seoul Address
5F, SB Tower, 318 Dosan-daero, Gangnam-Gu, Seoul 06054, Republic of Korea

 +82-2-6949-5350   
 [email protected]

© 2023 요즈마 그룹 코리아.

  • Korean
  • About
    • Chairman
    • Overview
    • People
      • Team
      • Advisors & Partners
      • Advisors & Partners
  • Business
  • YIC
  • Portfolio
  • Newsroom
  • Contact
Yozma Group Korea Co., Ltd

Seoul Address
5F, SB Tower, 318 Dosan-daero, Gangnam-Gu, Seoul 06054, Republic of Korea


 +82-2-6949-5350   
 [email protected]